On March 18, United Imaging Medical (688271) announced that it intends to increase the capital of its affiliated enterprise Shanghai United Imaging Intelligent Medical Technology Co., Ltd. (hereinafter referred to as "United Imaging Intelligence") with its own funds of 70 million yuan, subscribe for its new registered capital of 3.282906 million yuan, and obtain 0.70% of the equity after the capital increase.

After the completion of the transaction, United Imaging Healthcare's cumulative shareholding in United Imaging Intelligence will reach 0.9849%. The capital increase also includes the controlling shareholder United Imaging Group, the shareholder Shanghai Lianhe and other related parties, who participated in this round of financing with a shareholding ratio of 2% and 1.7901% respectively. According to the agreement, United Imaging Healthcare is required to pay 70 million yuan of investment within 15 working days after completing the registration of state-owned asset rights.

United Imaging Intelligence is positioned as a medical AI company, focusing on medical image analysis, intelligent diagnosis assistance, disease prediction and other fields, and has launched more than 100 AI products, covering clinical scenarios such as disease screening and early diagnosis. United Imaging Medical said that the investment aims to strengthen the intelligent ability of products and enhance the competitiveness of the high-end market.

On March 17, United Imaging Medical disclosed another shareholder dynamic: the company's fourth and fifth largest shareholders, Zhongke State Street, and Beiyuan Investment completed the inquiry transfer pricing, and planned to transfer 29.0864 million shares at a price of 108.66 yuan per share, accounting for 3.53% of the total share capital, and cashing out 3.161 billion yuan.

The transfer was participated by 29 institutional investors, with an effective subscription multiple of 2.26 times, and 25 institutions were allotted shares and required to be locked up for 6 months. In May 2024, the two transferred 9 million shares at 116.10 yuan per share, with a cumulative cash of more than 4.2 billion yuan. As of the close of trading on March 19, United Imaging Medical's share price was 129.07 yuan, a one-day increase of 1.23%.

According to the performance report, its revenue for the year was 10.3 billion yuan and the net profit attributable to the parent company was 1.262 billion yuan, a year-on-year decrease of 9.73% and 36.08% respectively, mainly due to the contraction of the industry scale and the increase in R&D investment. The related capital increase and shareholder reduction are parallel, highlighting the trend of strategic adjustment and capital operation.